CRVS logo

CRVS EV/EBITDA

Current (TTM)-16.35×
CRVS Quarterly EV/EBITDA (-52.44× → -79.10×)
High-resolution chart · PNG

CRVS ev/ebitda history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Corvus Pharmaceuticals Inc EV/EBITDA — Quarterly
Period endingEV/EBITDA
-79.1009×
-107.533×
-49.1574×
-60.0894×
-37.3308×
14.822×
-29.6071×
-8.654×
-22.7123×
-14.9341×
-11.3301×
-8.8916×
-15.944×
-4.4799×
-2.9842×
-1.1135×
-2.5082×
-5.8807×
-5.7339×
-13.6719×
-4.7867×
-5.5749×
-9.3602×
-10.0903×
-5.854×
-3.1743×
-14.0331×
-7.3083×
-7.2923×
-7.0087×
0.6606×
-18.1621×
-24.1014×
-10.9389×
-10.3716×
-22.2007×
-14.2371×
-25.7392×
-13.9959×
-31.6404×
-32.2857×
-2.0572×
10.6149×
-68.9026×
0×
-62.9266×
-52.4405×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.